Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system.

The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response.

Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.

Over 24 and 25 October, the congress will look into different issues, including communication for government health policies, the relationship between health institutions and journalists or crisis scenarios.

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The funds will strengthen research lines focused on nervous system tumors.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

Welcoming the students of the 1st edition of the Master’s in Clinical Trials Management and Coordination and the 11th edition of the Master’s in Translational Biomedical Research.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

The Vall d’Hebron Institute of Research’s Paediatric Cancer and Hematological Diseases Research Group Achieves Promising Results for Acute Graft-Versus-Host Disease.

This project of personalized and regenerative medicine will carry out the first clinical trial in Spain to treat burns and skin wounds with bioprinted autologous human skin substitutes.

This recognition highlights both his career and the level of respiratory research in Spain.

The Neonatology Service aims to demonstrate that the individual family room for newborns is more beneficial than the shared box room.

The ERS Awards recognize outstanding members for their exceptional contributions in the field of respiratory medicine.

The awarded study is titled “Perceptions and experiences of parents of premature newborns with an umbilical venous catheter who perform skin-to-skin contact,” and the granted scholarship will allow for its dissemination.

The Multidisciplinary Cancer Committee has evaluated a total of 701 patients since its creation.

The study aims to investigate how excess body fat alters the number and function of T lymphocytes, leading to a greater predisposition to infectious diseases.

The head of the Diagnostic Nanotools (DINA) group was part of a Spanish delegation that also participated in activities to establish contracts between national and international centers.

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

Around 150 people participated in a day filled with conferences, presentations, and networking activities.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

The report includes the centre's scientific and institutional highlights for 2023.